Community-Associated methicillin-resistant staphylococcus aureus nasal carriage in a college student athlete population

Clinical Journal of Sport Medicine

Volumn 20, Issue 3, 2010, Pages 185-188

  Rackham, Daniel ^a   Ray, Shaunta ^b,c   Franks, Andrea ^b,c   Bielak, Kenneth ^c   Pinn, Tanika ^c  

^a UNIVERSITY OF TENNESSEE MEDICAL CENTER   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF PHARMACY   (United States)

^c UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE   (United States)

Author keywords

Athlete; Carriage; College; Colonization; Community; MRSA

Indexed keywords

CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; LEVOFLOXACIN; LINEZOLID; OXACILLIN; PENICILLIN G; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; ATHLETE; COLLEGE STUDENT; FEMALE; HUMAN; INFECTION RATE; INFECTION RISK; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NOSE SMEAR; PRIORITY JOURNAL; UNITED STATES;

ATHLETES; CARRIER STATE; COMMUNITY-ACQUIRED INFECTIONS; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; NOSE; RISK FACTORS; STUDENTS; TENNESSEE; UNIVERSITIES; YOUNG ADULT;

EID: 77952005256     PISSN: 1050642X     EISSN: None     Source Type: Journal    
DOI: 10.1097/JSM.0b013e3181dba80d     Document Type: Article

References (24)

1. Centers for Disease Control and Prevention. CA-MRSA: Clinician FAQs. http://www.cdc.gov/ncidod/dhqp/ar-mrsa-ca-clinicians.html#8. Accessed June 29, 2009.
2. Lodise TP, Neuhauser MN. Community-associated methicillin-resistant Staphylococcus aureus. In: Dunsworth T, Richardson M, Chant C, et al, eds. Pharmacotherapy Self-Assessment Program (PSAP) : Infectious Diseases. 6th ed. Lenexa, KS: American College of Clinical Pharmacy; 2008:37-49.
3. Lindenmayer JM, Schoenfeld S, O'Grady R, et al. Methicillin-resistant Staphylococcus aureus in a high school wrestling team and the surrounding community. Arch Intern Med. 1998;158:895-899.
4. Begier EM, Frenette K, Barrett NL, et al. A high-morbidity outbreak of methicillin-resistant Staphylococcus aureus among players on a college football team, facilitated by cosmetic body shaving and turf burns. Clin Infect Dis. 2004;39:1446-1453.
5. Nguyen DM, Mascola L, Bancroft E. Recurring methicillin resistant Staphylococcus aureus infections in a football team. Emerg Infect Dis. 2005;11:526-532.
6. Stacey AR, Endersby KE, Chan PC, et al. An outbreak of methicillin resistant Staphylococcus aureus infection in a rugby football team. Br J Sports Med. 1998;32:153-154.
7. Kazakova SV, Hageman JC, Matava M, et al. A clone of methicillinresistant Staphylococcus aureus among professional football players. N Engl J Med. 2005;352:468-475.
8. Centers for Disease control and Prevention. Methicillin-resistant Staphylococcus aureus infections among competitive sports participants-Colorado, Indiana, Pennsylvania and Los Angeles County, 2000-2003. MMWR Morb Mortal Wkly Rep. 2003;52:793-795.
9. ABC News. Athletes vulnerable to dangerous staph infection. http://abcnews. go.com/WNT/Health/story?id=1580657. Accessed June 29, 2009.
10. ABC News. Superbug MRSAWorries Doctors, Athletes. http://abcnews.go. com/Health/Primetime/Story?id=410908&page=1. Accessed June 29, 2009.
11. CBS News. MRSA: Fighting the superbug. http://www.cbsnews.com/stories/ 2007/11/08/60minutes/main3474157.shtml. Accessed June 29, 2009.
12. Salgado CD, Farr BM, Calfee DP. Community-acquired methicillinresistant Staphylococcus aureus: a meta analysis of prevalence and risk factors. Clin Infect Dis. 2003;36:131-139.
13. Centers for Disease Control and Prevention. S. aureus and MRSA Surveillance Summary 2007. http://www.cdc.gov/ncidod/dhqp/ar-mrsa- surveillanceFS.html. Accessed June 29, 2009.
14. Kuehnert MJ, Kruszon-Moran D, Hill HA, et al. Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002. J Infect Dis. 2006;193:172-179.
15. Gorwitz RJ, Kruszon-Moran D, McAllister SK, et al. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. J Infect Dis. 2008;197:1226-1234.
16. Abudu L, Blair I, Fraise A, et al. Methicillin-resistant Staphylococcus aureus (MRSA) : a community-based prevalence survey. Epidemiol Infect. 2001;126:351-356.
17. Wertheim HF, Vos MC, Boelens HA, et al. Low prevalence of methicillinresistant Staphylococcus aureus (MRSA) at hospital admission in the Netherlands: the value of search and destroy and restrictive antibiotic use. J Hosp Infect. 2004;56:321-325.
18. Eveillard M, Martin Y, Hidri N, et al. Carriage of methicillin-resistant Staphylococcus aureus among hospital employees: prevalence, duration, and transmission to households. Infect Control Hosp Epidemiol. 2004;25:114-120.
19. Bischoff WE, Wallis ML, Tucker KB, et al. Staphylococcus aureus nasal carriage in a student community: prevalence, clonal relationships and risk factors. Infect Control Hosp Epidemiol. 2004;25:485-491.
20. Bassetti S, Wolfisberg L, Jaussi B, et al. Carriage of Staphylococcus aureus among injection drug users: lower prevalence in an injection heroin maintenance program than in an oral methadone program. Infect Control Hosp Epidemiol. 2004;25:133-137.
21. Creech CB, Kernodle DS, Alsentzer A, et al. Increasing rates of methicillin-resistant Staphylococcus aureus in healthy children. Pediatr Infect Dis J. 2005;24:617-621.
22. Jernigan JA, Arnold K, Heilpern K, et al. Methicillin resistant Staphylococcus aureus as community pathogen [conference summary]. Emerg Infect Dis. [serial on the Internet]. 2006 Nov. http://www.cdc.gov/ncidod/eid/ vol12no11/06-0911.htm. Accessed June 29, 2009.
23. Beam JW, Buckley B. Community-acquired methicillin resistant Staphylococcus aureus: prevalence and risk factors. J Athl Train. 2006;41:337-340.
24. Mertz D, Frei R, Periat N. Exclusive Staphylococcus aureus throat carriage: at risk populations. Arch Intern Med. 2009;169:172-178.